The largest database of trusted experimental protocols
> Disorders > Sign or Symptom > Low Back Pain

Low Back Pain

Low Back Pain refers to pain experienced in the lower back region.
It is a common condition that can be caused by a variety of factors, including muscle strain, herniated discs, arthritis, and injuries.
Symptoms may include dull, achy pain, sharp or stabbing sensations, and limited mobility.
Effective management often involves a combination of treatments, such as physical therapy, medication, and lifestyle modifications.
Researching the latest protocols and products for low back pain can help enhance the reproducibility of studies and drive breakthroughs in pain management.
Experieince the power of AI-driven research today with PubCompare.ai, the leading platform for optimizing low back pain research.

Most cited protocols related to «Low Back Pain»

The pre-final standards, criteria, and rating system were pilot-tested by five authors (CB, CP, AC, HV, and LM) in a systematic review of PROMs measuring physical functioning in patients with low back pain [19 (link)] and in a systematic review of PROMs for hand osteoarthritis (manuscript in preparation). Issues that came up during the pilot test were discussed within the steering committee, resulting in final changes in the standards, criteria, and rating system. The rating system was also discussed with the chairman of the Dutch GRADE network. Finally, the “COSMIN Methodology for assessing the content validity of PROMs—user manual” was written, available from http://www.cosmin.nl.
Publication 2018
Degenerative Arthritides Low Back Pain Patients Physical Examination

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2018
Acquired Immunodeficiency Syndrome Aortic Aneurysm Caribbean People Disabled Persons Disorder, Attention Deficit-Hyperactivity Ethnicity Headache Disorders Low Back Pain Maternal Death Microtubule-Associated Proteins Neck Pain Population Group Sudden Infant Death Syndrome
In GBD 2017, as in previous GBDs, causes of mortality and morbidity are structured using a four-level classification hierarchy to produce results that are mutually exclusive and collectively exhaustive. GBD 2017 estimates 359 causes of DALYs, 77 of which are a source of disability but not a cause of death (eg, attention-deficit hyperactivity disorder, headache disorders, low back pain, and neck pain), and five of which are causes of death but not sources of morbidity (sudden infant death syndrome, aortic aneurysm, late maternal deaths, indirect maternal deaths, and maternal deaths aggravated by HIV/AIDS). In the GBD hierarchy, the number of mutually exclusive and collectively exhaustive fatal and non-fatal causes in each level for which GBD estimates is three at Level 1, 22 at Level 2, 169 at Level 3, and 293 at Level 4. The full GBD cause hierarchy, including corresponding International Classification of Diseases (ICD)-9 and ICD-10 codes and detailed cause-specific methods, is in GBD 2017 publications on cause-specific mortality11 and non-fatal health outcomes12 in the corresponding appendices.
GBD 2017 includes 195 countries and territories that are grouped into 21 regions on the basis of epidemiological similarities and geographical proximity.15 (link) For the purposes of statistical analyses, we further grouped regions into seven super-regions (central Europe, eastern Europe, and central Asia; high income; Latin America and Caribbean; north Africa and Middle East; south Asia; southeast Asia, east Asia and Oceania; and sub-Saharan Africa). Each year, GBD includes subnational analyses for a few new countries and continues to provide subnational estimates for countries that were added in previous cycles. Subnational estimation in GBD 2017 includes five new countries (Ethiopia, Iran, New Zealand, Norway, and Russia) and countries previously estimated at subnational levels (GBD 2013: China, Mexico, and the UK [regional level]; GBD 2015: Brazil, India, Japan, Kenya, South Africa, Sweden, and the USA; and GBD 2016: Indonesia and the UK [local government authority level]). All analyses are at the first level of administrative organisation within each country except for New Zealand (by Māori ethnicity), Sweden (by Stockholm and non-Stockholm), and the UK (by local government authorites). All subnational estimates for these countries were incorporated into model development and evaluation as part of GBD 2017. To meet data use requirements, we present all subnational estimates excluding those pending publication (Brazil, India, Japan, Kenya, Mexico, Sweden, the UK, and the USA); these results are presented in appendix tables and figures (appendix 2). Subnational estimates for countries with populations larger than 200 million people (as measured according to our most recent year of published estimates) that have not yet been published elsewhere are presented wherever estimates are illustrated with maps but are not included in data tables.
Publication 2018
Acquired Immunodeficiency Syndrome Aortic Aneurysm Caribbean People Disabled Persons Disorder, Attention Deficit-Hyperactivity Ethnicity Headache Disorders Low Back Pain Maternal Death Microtubule-Associated Proteins Neck Pain Population Group Sudden Infant Death Syndrome
The COSMIN initiative83 (link) previously identified 9 measurement properties relevant for PROMs: internal consistency, test-retest reliability, measurement error, construct validity, structural validity, criterion validity, cross-cultural validity, and responsiveness.85 (link) Three systematic reviews (for physical functioning, pain intensity and HRQoL) summarized and appraised the evidence on these measurement properties in patients with nsLBP (Chiarotto et al., 2018. Measurement properties of Numeric Rating Scale, Visual Analogue Scale and Pain Severity subscale of Brief Pain Inventory in patients with low back pain: a systematic review: Unpublished data; Chiarotto et al., 2018. Evidence on the measurement properties of health-related quality of life instruments is largely missing in patients with low back pain, a systematic review: Unpublished data; and Ref. 18). These reviews were conducted according to the recently updated COSMIN methodology for this type of reviews (Prinsen et al., 2018. COSMIN guideline for systematic reviews of patient-reported outcome measures: Unpublished data); a more detailed description of their methodology is presented elsewhere (Chiarotto et al., 2018. Measurement properties of Numeric Rating Scale, Visual Analogue Scale and Pain Severity subscale of Brief Pain Inventory in patients with low back pain: a systematic review: Unpublished data; Chiarotto et al., 2018. Evidence on the measurement properties of health-related quality of life instruments is largely missing in patients with low back pain, a systematic review: Unpublished data; and Ref. 18).
Publication 2018
Back Pain Low Back Pain Patients Physical Examination Severity, Pain Visual Analog Pain Scale
The Oswestry Disability Index (ODI) version 2.1 is a self-administered questionnaire measuring "back-specific function" with reference to "today" on a 10 item scale with six response categories each. Each item scores from 0 to 5 and the score is subsequently transformed into 0–100 [2 (link),59 ,60 (link),60 (link)].
The 23-item version of the Roland Morris Disability Questionnaire (RMQ) was developed specifically to target LBP patients with radicular symptoms and is a modification of the original RMQ [61 (link)]. We chose the 23-item version instead of the original 24-item version [62 (link)] for two reasons: 1) the 23-item version has been cross-culturally validated in Danish whereas the 24-item version has not, and 2) the psychometric properties of the two versions have been shown to be similar [63 (link)]. Each item is scaled as yes/no (scored as 1 and 0 points respectively) with the scale ranging from 0 (no disability) to 23 (extremely severe disability).
The Low Back Pain Rating Scale (LBPRS) was developed to measure the dimensions of pain, disability and physical impairment for patients with LBP [64 (link)]. The pain assessment index (LBPRSpain) is measured on 0 to 10 numerical scales with 0 representing no pain and 10 representing worst possible pain. There were three 11-box numeric rating scales (pain now, worst and average pain in the last 2 weeks) for back pain and leg pain separately. Each response scale score is added giving a scale range of 0–60 points. The disability index (LBPRSdisability) comprises 15 items scaled as yes = 0 points, can be a problem = 1 points, no = 2 points, giving a total score of 0–30 points.
The SF36 is a generic 36-item questionnaire compiled from the Rand Health Insurance Long Form Health Status Scale [65 (link)]. Of the eight dimensions, we included the physical function (SF36 (pf)) and the bodily pain (SF36 (bp)) subscales. Questions are framed over a one-week period with response scales varying from dichotomous (yes/no) to six-point verbal rating scales. Each dimension is scored on a weighted 0–100 scale and an overall score is recommended [66 ].
Back and/or leg pain was scored on an 11-box numeric rating scale (pain now) from 0 (no pain) to 10 (worst possible pain) [67 (link),68 (link)].
The patients' global retrospective assessment of treatment effect (transition question) was used to assess the patients' perception of their overall change in their back condition. A 7-point Likert scale transition question (TQ) ranging from "much better" to "much worse" was used [69 (link)]. Furthermore, the importance of the change in health state experienced was measured. All patients were asked to rate the question: "How important is the change you have experienced in your back and/or leg pain since the start of the treatment?" on a 0 – 10 numeric rating scale (NRSimp) with "very important" and "not at all important" at the extremes.
This information was collected by telephone interviews which followed a carefully planned protocol. First, all patients were told their baseline global rating of pain severity (NRSpain) before answering the TQ to ensure optimal patient focus on the change in health rather than the present health state [70 (link),71 (link)]. Second, the transition question with response options was read twice. In case the patient was uncertain of which response to choose, the interviewer determined whether the patient was either better, had not changed or worse. If the interviewer decided that the patient was better the categories for being improved was read again ("much better", "better", "a little better") and similar for patients classified as worse.
All the included disability instruments have been cross-culturally adapted and validated in Danish [56 ,57 ,64 (link),72 (link)-75 (link)]. For a complete description of the psychometric properties of each instrument we refer the reader to relevant literature reviews [2 (link)-4 (link),60 (link),76 (link)-78 (link)].
Publication 2006
Back Pain Disabled Persons Generic Drugs Interviewers Low Back Pain Pain Pain Measurement Patients Physical Examination Psychometrics Severity, Pain

Most recents protocols related to «Low Back Pain»

An electronic survey was used to gather information on weight and height in order to calculate each participant’s Body Mass Index (BMI). Climbing level for the last 12 months was collected and classified according to the recommendations of the IRCRA [18 (link)]. The prevalence of jumping descent in bouldering was recorded through questions designed by the authors.
The Nordic questionnaire of back pain [19 (link)], adjusted for sport specific settings [20 (link)], was used to examine the lifetime and one-year prevalence of thoracolumbar back pain as well as training volume of the participants. The Nordic questionnaire of back pain has shown acceptable test–retest reliability and validity to clinical examination [19 (link), 20 (link)]. Based on the sport adjusted Nordic questionnaire, questions focusing on training volume between 10 and 20 years of age were computed, since athletes are plausibly more susceptible to develop radiographic spinal changes of the spine during the growth spurt [13 (link), 21 (link)]. The Oswestry back pain disability index [22 (link)] was used to examine disability associated to thoracic and lumbar back pain.
Publication 2023
Athletes Back Pain Disabled Persons Index, Body Mass Low Back Pain Physical Examination Vertebral Column X-Rays, Diagnostic
During this background phase, the principal investigator (G.D.S.) and a research assistant (A.G.) reviewed literature and conducted a panel discussion with PCPs and communication experts (n = 5). Based on the findings from this stage, 4 clinical vignettes were developed. The vignettes described the following general medical diagnostic uncertainty scenarios: (1) enlarged lymph node in a patient with a history of lymphoma in remission (ie, worrisome for a recurrence), (2) new-onset headache, (3) fever and upper respiratory infection, and (4) subacute low back pain (eAppendix 2 in Supplement 1).
Publication 2023
Diagnosis Dietary Supplements Fever Headache Low Back Pain Lymphoma Nodes, Lymph Patients Pneumocystosis Recurrence Upper Respiratory Infections
Following the institutional review board approval for the study (number: 119/2019; Muğla Sıtkı Koçman University Ethical Committee), a retrospective cohort analysis was performed using the medical records of patients. For the current study, patient consent is not required. All procedures executed involving human participants were in accordance with the ethical standards of the institutional ethical committee and with the 1964 Helsinki declaration.
A total of 146 patients who applied to the neurosurgery outpatient clinic with a recent abdominal CT (max three months) because of a lower back pain complaint were included in the study. Patients with a previous history of surgery or a vertebral fracture were excluded. After excluded patients, a total of 146 patients were included in the study, of whom 90 were female (61.6%) and 56 were male (38.4%). The mean age of the patients was 51.42±13.91 (20-82) years.
Lumbar vertebra CT scans of all patients were reviewed retrospectively. CT images at the level from L3-L4 intervertebral disc were analyzed for body composition of fat tissue and muscle mass volume through the dedicated CT software (Syngo.via, SOMATOM Definition Flash: Siemens Healthcare, Forchheim, Germany). The L3-L4 level was selected in sagittal reformat CT images with the software (Figure 1).
The density range of -200, -40 HU was selected for the fat density measurement in the cross-section with the "region grooving" application in the angled axial images obtained parallel to the disc plane at this level. First, the fat volume in the whole section was measured (visceral and subcutaneous). Then, only the visceral adipose tissue volume was calculated by drawing borders to exclude subcutaneous adipose tissue (Figure 2). The subcutaneous fat tissue volume was obtained by subtracting the visceral fat tissue volume from the total fat volume (Figure 3).
With the same application, muscle density was selected and paravertebral muscle tissue volume was calculated (bilateral musculus psoas major, musculus quadratus lumborum, musculus iliocostalis, musculus longissimus, musculus multifidus volumes). A Spearman correlation model was used to analyze visceral adiposity, subcutaneous fat, and muscle mass.
In CT images, each intervertebral disc space was evaluated in terms of the presence of osteophytes, loss of disc height, sclerosis in the end plates, and spinal stenosis (spinal canal narrowing under 15 mm AP diameter) to investigate the presence of degeneration. Each level was scored according to the presence of findings, with 1 point for the presence of osteophytes, loss of disc height, sclerosis in the end plates, and spinal stenosis. The total score at all levels (L1-S1) was calculated for each patient.
Statistical analyses were performed using IBM SPSS version 20.0 software (IBM Corp., Armonk, NY). The conformity of the data to normal distribution was assessed using the Shapiro-Wilk test. Normally distributed variables were presented as mean±standard deviation and those not showing normal distribution as median (minimum-maximum) values. Categorical variables were presented as numbers (n) and percentages (%). The Spearman's rank correlation coefficient test was used to determine the correlation between the measured parameters in various vertebral pathologies. Continuous variables were compared using the Mann-Whitney U test. The receiver operating characteristic (ROC) analysis was used to detect the area under the curve (AUC) and define the cutoff values with their sensitivities and specificities of the measurements. An alpha value of p<0.05 was accepted as statistically significant.
Publication 2023
Abdomen Cone-Beam Computed Tomography Ethics Committees, Research Homo sapiens Intervertebral Disc Low Back Pain Males Multifidus Muscle Tissue Neurosurgical Procedures Obesity, Visceral Operative Surgical Procedures Osteophyte Patients Psoas Muscles Pulp Canals Sclerosis Spinal Fractures Spinal Stenosis Subcutaneous Fat Vertebra Vertebrae, Lumbar Visceral Fat Woman X-Ray Computed Tomography
Female college students enrolled in the 2016–17 academic year at IAU who were aged 18–25 years, had a body mass index ranged between 18–30, and a reduced hamstring muscle length (hamstring tightness), as defined by the literature (popliteal angle <160°) were eligible for inclusion.[33 (link)]
Students with lower limb musculoskeletal disease, abdominal, lower limb and spinal surgery, pregnancy, previous injury or trauma to hamstring muscle, hip, knee or ankle joints, skin allergy, low back pain, or any neurological impairment in the lower extremity were excluded.[1 (link)14 (link)31 (link)]
Publication 2023
Abdomen Hamstring Muscle Hypersensitivity Index, Body Mass Injuries Joints, Ankle Knee Joint Low Back Pain Lower Extremity Musculoskeletal Diseases Operative Surgical Procedures Pregnancy Skin Student Woman Wounds and Injuries
The literature retrieved for this study was published in both English and Chinese. Articles published from the inception of the database to April 2022 were retrieved from the PubMed, Embase, Cochrane Library, and Clinical Trials databases and Chinese databases, such as the Chinese National Knowledge Infrastructure, Chongqing VIP Chinese Scientific Journals, Wang Fang, and Chinese Biomedicine. The MeSH terms “platelet-rich plasma” and “low back pain” or their entry terms were used as the search terms (a detailed PubMed database search strategy is shown in Figure 1). To collect more eligible studies, a reference list of retrieved studies and related reviews was manually searched, and the process was repeated until no further articles were identified.
Publication 2023
cDNA Library Chinese Low Back Pain Platelet-Rich Plasma

Top products related to «Low Back Pain»

Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, Austria, Japan, Belgium, United Kingdom, Cameroon, China, Denmark, Canada, Israel, New Caledonia, Germany, Poland, India, France, Ireland, Australia
SAS 9.4 is an integrated software suite for advanced analytics, data management, and business intelligence. It provides a comprehensive platform for data analysis, modeling, and reporting. SAS 9.4 offers a wide range of capabilities, including data manipulation, statistical analysis, predictive modeling, and visual data exploration.
Sourced in United States, Japan, United Kingdom, Germany, Austria, Belgium, Denmark, China, Israel, Australia
SPSS version 21 is a statistical software package developed by IBM. It is designed for data analysis and statistical modeling. The software provides tools for data management, data analysis, and the generation of reports and visualizations.
Sourced in United States, United Kingdom, Germany, Canada, China, Switzerland, France, Ireland, Italy, Japan
Collagenase type II is a digestive enzyme used to break down collagen, a structural protein found in various tissues. It is commonly utilized in cell isolation and tissue dissociation procedures to facilitate the extraction of cells from their extracellular matrix. The enzyme's ability to cleave collagen molecules makes it a valuable tool in biological research and cell culture applications.
Sourced in United States, Japan
JMP version 14 is a statistical discovery software from SAS Institute. It provides data analysis and visualization tools for users to explore and understand their data. The software supports a variety of data formats and offers features for data manipulation, modeling, and reporting.
Sourced in United States
Fungiozone is a laboratory product used for the detection and identification of fungal species. It provides a reliable and efficient method for analyzing fungal samples.
Sourced in Japan
The DCS-600EX is a diagnostic imaging system designed for medical applications. It provides high-quality digital images to support clinical decision-making. The system features advanced imaging technology and is intended for use by trained medical professionals.
Sourced in United States, Denmark, United Kingdom, Austria, Sweden
Stata 13 is a comprehensive, integrated statistical software package developed by StataCorp. It provides a wide range of data management, statistical analysis, and graphical capabilities. Stata 13 is designed to handle complex data structures and offers a variety of statistical methods for researchers and analysts.
Sourced in United States, Denmark, Austria, United Kingdom, Japan, Canada
Stata version 14 is a software package for data analysis, statistical modeling, and graphics. It provides a comprehensive set of tools for data management, analysis, and reporting. Stata version 14 includes a wide range of statistical techniques, including linear regression, logistic regression, time series analysis, and more. The software is designed to be user-friendly and offers a variety of data visualization options.

More about "Low Back Pain"

Low back pain (LBP), also known as lumbago, is a common musculoskeletal condition that affects the lower back region.
It can be caused by a variety of factors, including muscle strain, herniated or bulging discs, arthritis, and injuries.
Symptoms may include dull, achy pain, sharp or stabbing sensations, and limited mobility.
Effective management of low back pain often involves a combination of treatments, such as physical therapy, medication, and lifestyle modifications.
Researching the latest protocols and products for low back pain can help enhance the reproducibility of studies and drive breakthroughs in pain management.
Some key subtopics related to low back pain include: - Anatomy of the lower back - Common causes of low back pain (e.g., muscle strain, disc herniation, osteoarthritis) - Diagnostic methods (e.g., physical examination, imaging tests) - Conservative treatments (e.g., physical therapy, exercise, pain medication) - Surgical interventions (e.g., spinal decompression, fusion) - Complementary and alternative therapies (e.g., acupuncture, massage) - Risk factors and prevention strategies Experieince the power of AI-driven research today with PubCompare.ai, the leading platform for optimizing low back pain research.
Discover how this tool can help you locate protocols from literature, pre-prints, and patents, and use intelligent comparisons to identify the best protocols and products.
Enhance the reproducibility of your studies and drive breakthroughs in low back pain management.